Promino Nutritional Sciences Inc
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Vito Sanzone
- Full Time Employees
- 9
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 4145 North Service Road Burlington ON Canada L7L 6A3
- IPO Date
- Oct 25, 2021
- Website
- drinkpromino.com
- Similar Companies
- Business
- Promino Nutritional Sciences Inc. engages in the development, manufacture, and distribution of science-based muscle health and performance nutrition products for the global consumer packaged goods market. The company focuses on patented essential amino acid formulations intended to support muscle growth, recovery, and maintenance, including branded offerings such as Rejuvenate Muscle Activator and Promino products, marketed under Promino and JAKTRX brands for athletes and fitness enthusiasts. Promino operates primarily in Canada and the United States, with distribution partners and retail channels across North America and online platforms to reach amateur and professional athletes, fitness communities, and healthcare-conscious consumers. The company was founded in 2015 and is headquartered in Burlington, Ontario. Promino’s portfolio combines consumer-facing dietary supplements with research-backed nutrition solutions, targeting growth in sports nutrition, rehabilitation, and preventive health markets through partnerships, clinical collaborations, and ongoing product development initiatives. The organization maintains a focus on expanding distribution, advancing preclinical and clinical research for oncology-associated muscle wasting initiatives, and pursuing product innovations within its amino acid-based portfolio to differentiate in the nutraceutical space. Subsidiaries and potential parent relationships are aligned to support regional marketing, regulatory compliance, and manufacturing scale to meet rising demand.
Rejuvenate Muscle Health(TM) Expands its Position in the Emerging GLP-1 Muscle Health Category with U.S. Pharmacy Program and National E-Commerce Expansion
Promino Launches Muscle Health Research Initiative Targeting GLP-1 Weight Management Market
Promino Announces Settlements and Amendments of Convertible Debentures
Promino Announces Sponsorship of Team Canada Speedsoft for 2026 International Competition Season
Promino Announces Multi-Platform E-Commerce Growth with "Drink Rej(TM)" Launch as Initial Rejuvenate Muscle Health(TM) Inventory Arrives
Promino Announces Closing of Final Tranche of Private Placement
Promino Announces Closing of Third Tranche of Private Placement
Promino Announces Closing of Second Tranche of Private Placement
Promino Responds to Growing Demand for Muscle Health Support as Health Canada Expands Access to Semaglutide
Promino Nutritional Sciences Reports Fiscal 2025 Results, Delivering Revenue Growth and Improved Financial Performance
Promino Provides Update Respecting Private Placement
Promino Nutritional Sciences Launches NCAA Division I Athlete Platform Through Multi-Sport NIL Partnership with Virginia Military Institute
Promino Advances Rejuvenate Platform as Muscle Health Emerges as High-Growth Functional Beverage Category
Promino Nutritional Sciences Inc. Initiates Largest Production Run in Company History - Approximately 3.5 Million Servings of Rejuvenate Muscle Health(R)
Promino Announces Proposed Private Placement
Rejuvenate Muscle Health(TM) Nears 10,000 Points of Distribution as Major U.S. Retailer Expands Functional Beverage Breakout by 2,105 Stores
Promino Announces Closing of Private Placement
Promino Announces Secured Convertible Debenture Offering for Proceeds of up to $1 Million
Rejuvenate Muscle Health Wins Prestigious "Best Drink" Award at 2025 ECRM Vitamin, Weight Management & Sports Nutrition Session
CSE Bulletin: Reinstatement - Promino Nutritional Sciences Inc. (MUSL)